[1] Takeda S, Takeda J, Murayama Y. Placenta previa accreta spectrum:Cesarean hysterectomy[J]. The Surgery Journal, 2021, 7(Suppl 1):S28-S37. [2] Matsuzaki S, Nagase Y, Ueda Y, et al. The association of endometriosis with placenta previa and postpartum hemorrhage:A systematic review and meta-analysis[J]. American Journal of Obstetrics & Gynecology MFM, 2021, 3(5):100417. [3] Fan D Z, Rao J M, Lin D X, et al. Anesthetic management in cesarean delivery of women with placenta previa:A retrospective cohort study[J]. BMC Anesthesiology, 2021, 21(1):247. [4] 张晓敏, 邓秀, 池敏珊. 盐酸利托君联合阿托西班治疗前置胎盘的临床疗效及安全性分析[J]. 中国医学工程, 2021, 29(11):110-112. [5] Wu F, Chen Y, Zheng C H. Efficacy of phloroglucinol for acceleration of labour:A systematic review and meta-analysis[J]. Archives of Gynecology and Obstetrics, 2021, 304(2):421-428. [6] 谢幸, 苟文丽. 妇产科学[M]. 8版. 北京:人民卫生出版社, 2013:126-135. [7] Cnattingius S, Johansson S, Razaz N. Apgar score and risk of neonatal death among preterm infants[J]. The New England Journal of Medicine, 2020, 383(1):49-57. [8] Liu Z P, Fan D Z, Lin D X, et al. Double-uterine-incision in the management of placenta previa complicated by placenta accreta spectrum[J]. American Journal of Translational Research, 2021, 13(11):13017-13023. [9] Jauniaux E, Grφnbeck L, Bunce C, et al. Epidemiology of placenta previa accreta: A systematic review and meta-analysis[J]. British Medical Journal Open, 2019, 9(11):e031193. [10] Timor-Tritsch I E, Monteagudo A, Calì G, et al. Cesarean scar pregnancy:Diagnosis and pathogenesis[J]. Obstetrics and Gynecology Clinics of North America, 2019, 46(4):797-811. [11] Bi S L, Zhang L Z, Wang Z J, et al. Effect of types of placenta previa on maternal and neonatal outcomes:A 10-year retrospective cohort study[J]. Archives of Gynecology and Obstetrics, 2021, 304(1):65-72. [12] Liu B, Deng S Q, Lin M F, et al. Prediction of cesarean hysterectomy in placenta previa complicated with prior cesarean:A retrospective study[J]. BMC Pregnancy and Childbirth, 2020, 20(1):81. [13] Nagase Y, Matsuzaki S, Endo M, et al. Placenta previa with posterior extrauterine adhesion:Clinical features and management practice[J]. BMC Surgery, 2021, 21(1):10. [14] Fu S, Xie H T, Zhong Y L, et al. Atosiban combined with ritodrine for late threatened abortion or threatened premature labor patients with no response to ritodrine:A clinical trial[J]. Medical Science Monitor, 2021, 27:e929743. [15] Shigemi D, Aso S, Yasunaga H. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan:A retrospective cohort study using a national inpatient database[J]. BMC Pregnancy and Childbirth, 2019, 19(1):204. [16] 金婷婷, 卢莹莹, 李思聪. 盐酸利托君、间苯三酚用于孕20周后先兆流产的保胎效果对比研究[J]. 中国妇产科临床杂志, 2022, 23(3):293-294. [17] 李军. 安宝、硫酸镁和间苯三酚在孕20周后先兆流产中的临床疗效和安全性探讨[J]. 中国现代药物应用, 2020, 14(10):157-158. [18] 曹琪. 间苯三酚与盐酸利托君治疗前置胎盘临床效果分析[J]. 泰山医学院学报, 2017, 38(7):778-779. [19] 周仲元, 王晓娟, 李秀芳. 腹主动脉球囊阻断术联合子宫重塑术治疗凶险性前置胎盘伴胎盘植入疗效[J]. 中国计划生育学杂志, 2022, 30(1):189-192. [20] Berezowsky A, Pardo J, Ben-Zion M, et al. Second trimester biochemical markers as possible predictors of pathological placentation:A retrospective case-control study[J]. Fetal Diagnosis and Therapy, 2019, 46(3):187-192. [21] Zhang F Y, Gu M Q, Chen P Z, et al. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio[J]. Placenta, 2022, 124:48-54. [22] 刘晓宁, 宋振霞, 潘晓华. 前置胎盘患者血清及胎盘组织中Eph A5表达水平与妊娠结局的关系探讨[J]. 临床输血与检验, 2020, 22(3):326-328, 333. [23] 解艳华, 张庆桥, 朱秀娟, 等. 产前三维能量多普勒超声预测前置胎盘患者剖宫产术中出血量[J]. 中国医学影像技术, 2019, 35(7):1076-1080. |